| 0 |
NEUROLEUKAEMIOSIS |
2 |
0.5000 |
| 1 |
CYTARABINE SYNDROME |
32 |
0.4211 |
| 2 |
CLOSTRIDIUM TEST |
11 |
0.3548 |
| 3 |
DELAYED HAEMATOPOIETIC RECONSTITUTION |
2 |
0.2222 |
| 4 |
ACUTE POST ASTHMATIC AMYOTROPHY |
1 |
0.1667 |
| 5 |
CATHETER SITE ECZEMA |
1 |
0.1429 |
| 6 |
CORYNEBACTERIUM BACTERAEMIA |
11 |
0.1294 |
| 7 |
BONE MARROW HAEMORRHAGE |
1 |
0.1250 |
| 8 |
ANTI-HLA ANTIBODY TEST POSITIVE |
2 |
0.1176 |
| 9 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
15 |
0.0872 |
| 10 |
POSITIVE END-EXPIRATORY PRESSURE |
1 |
0.0833 |
| 11 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
177 |
0.0824 |
| 12 |
URTICARIA VESICULOSA |
3 |
0.0789 |
| 13 |
CEREBELLAR EMBOLISM |
2 |
0.0690 |
| 14 |
SEPTAL PANNICULITIS |
5 |
0.0625 |
| 15 |
MYELOBLAST PERCENTAGE INCREASED |
1 |
0.0476 |
| 16 |
CORYNEBACTERIUM SEPSIS |
3 |
0.0455 |
| 17 |
LEUKAEMIC INFILTRATION PULMONARY |
2 |
0.0435 |
| 18 |
BLAST CELLS PRESENT |
20 |
0.0416 |
| 19 |
BLAST CELL COUNT INCREASED |
41 |
0.0391 |
| 20 |
MYELOBLAST COUNT INCREASED |
3 |
0.0390 |
| 21 |
TONGUE EROSION |
1 |
0.0385 |
| 22 |
STENOTROPHOMONAS TEST POSITIVE |
5 |
0.0373 |
| 23 |
ABNORMAL PRECORDIAL MOVEMENT |
1 |
0.0370 |
| 24 |
ACUTE ERYTHROID LEUKAEMIA |
2 |
0.0317 |
| 25 |
PARVOVIRUS B19 INFECTION REACTIVATION |
1 |
0.0312 |
| 26 |
STENOTROPHOMONAS MALTOPHILIA PNEUMONIA |
2 |
0.0290 |
| 27 |
HEPATOSPLENIC CANDIDIASIS |
4 |
0.0272 |
| 28 |
ELECTROCARDIOGRAM LOW VOLTAGE |
2 |
0.0263 |
| 29 |
DISSEMINATED VARICELLA |
1 |
0.0263 |
| 30 |
STENOTROPHOMONAS BACTERAEMIA |
2 |
0.0263 |
| 31 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
4 |
0.0231 |
| 32 |
BLOOD COPPER INCREASED |
4 |
0.0225 |
| 33 |
SEPTIC PULMONARY EMBOLISM |
4 |
0.0205 |
| 34 |
ACUTE MYELOID LEUKAEMIA |
313 |
0.0201 |
| 35 |
CONGENITAL APLASIA |
6 |
0.0193 |
| 36 |
REFRACTORINESS TO PLATELET TRANSFUSION |
2 |
0.0183 |
| 37 |
PULMONARY HAEMATOMA |
2 |
0.0171 |
| 38 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
11 |
0.0168 |
| 39 |
STENOTROPHOMONAS SEPSIS |
2 |
0.0165 |
| 40 |
HERPES SIMPLEX VIRAEMIA |
2 |
0.0160 |
| 41 |
OVARIAN NECROSIS |
1 |
0.0159 |
| 42 |
ACANTHOLYSIS |
1 |
0.0152 |
| 43 |
FIBRINOLYSIS |
1 |
0.0147 |
| 44 |
HEPATIC CANDIDIASIS |
1 |
0.0147 |
| 45 |
TRANSPLANTATION COMPLICATION |
6 |
0.0143 |
| 46 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
4 |
0.0141 |
| 47 |
MYRINGITIS |
1 |
0.0135 |
| 48 |
ENTEROBACTER BACTERAEMIA |
4 |
0.0132 |
| 49 |
PRE-ENGRAFTMENT IMMUNE REACTION |
1 |
0.0125 |
| 50 |
RED BLOOD CELL TRANSFUSION |
5 |
0.0122 |
| 51 |
SCLERAL OEDEMA |
1 |
0.0120 |
| 52 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
3 |
0.0118 |
| 53 |
TOXIC ERYTHEMA OF CHEMOTHERAPY |
3 |
0.0116 |
| 54 |
ANTI-PLATELET ANTIBODY POSITIVE |
2 |
0.0116 |
| 55 |
OSTEORRHAGIA |
1 |
0.0114 |
| 56 |
INFECTIVE THROMBOSIS |
1 |
0.0112 |
| 57 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
10 |
0.0108 |
| 58 |
VITAMIN C DEFICIENCY |
2 |
0.0103 |
| 59 |
NASAL HERPES |
2 |
0.0099 |
| 60 |
THROMBOPHLEBITIS SEPTIC |
2 |
0.0098 |
| 61 |
IMMOBILISATION SYNDROME |
2 |
0.0094 |
| 62 |
BACILLUS BACTERAEMIA |
1 |
0.0092 |
| 63 |
SUBDIAPHRAGMATIC ABSCESS |
1 |
0.0089 |
| 64 |
MUCOUS MEMBRANE PEMPHIGOID |
1 |
0.0088 |
| 65 |
FUSARIUM INFECTION |
6 |
0.0086 |
| 66 |
HUMAN METAPNEUMOVIRUS TEST POSITIVE |
1 |
0.0085 |
| 67 |
DERMO-HYPODERMITIS |
5 |
0.0084 |
| 68 |
ROSEOLOVIRUS TEST POSITIVE |
1 |
0.0082 |
| 69 |
DERMATOSIS |
5 |
0.0080 |
| 70 |
FEBRILE NEUTROPENIA |
528 |
0.0080 |
| 71 |
ANAL INFECTION |
2 |
0.0078 |
| 72 |
NEUTROPENIC COLITIS |
16 |
0.0077 |
| 73 |
APLASIA |
15 |
0.0077 |
| 74 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
3 |
0.0076 |
| 75 |
ENTEROCOCCAL BACTERAEMIA |
8 |
0.0075 |
| 76 |
ASPIRATION BONE MARROW |
1 |
0.0075 |
| 77 |
TUMOUR ASSOCIATED FEVER |
3 |
0.0073 |
| 78 |
ATYPICAL MYCOBACTERIAL PNEUMONIA |
1 |
0.0072 |
| 79 |
URETERITIS |
2 |
0.0071 |
| 80 |
LEUKAEMIC INFILTRATION |
1 |
0.0071 |
| 81 |
CHLOROMA |
3 |
0.0071 |
| 82 |
OROPHARYNGEAL OEDEMA |
1 |
0.0069 |
| 83 |
ANAL FISTULA INFECTION |
1 |
0.0067 |
| 84 |
CYTOPENIA |
81 |
0.0066 |
| 85 |
FEBRILE BONE MARROW APLASIA |
28 |
0.0066 |
| 86 |
RASH FOLLICULAR |
1 |
0.0065 |
| 87 |
LEUKAEMIA CUTIS |
1 |
0.0065 |
| 88 |
PNEUMONIA CHLAMYDIAL |
1 |
0.0064 |
| 89 |
PNEUMONIA FUNGAL |
25 |
0.0063 |
| 90 |
ALLOGENIC STEM CELL TRANSPLANTATION |
1 |
0.0063 |
| 91 |
STENOTROPHOMONAS INFECTION |
8 |
0.0059 |
| 92 |
CATHETER SITE ABSCESS |
1 |
0.0057 |
| 93 |
KLEBSIELLA SEPSIS |
6 |
0.0053 |
| 94 |
SCROTAL ABSCESS |
2 |
0.0053 |
| 95 |
MENINGOCOCCAL SEPSIS |
1 |
0.0053 |
| 96 |
STREPTOCOCCAL URINARY TRACT INFECTION |
1 |
0.0052 |
| 97 |
BACTERAEMIA |
58 |
0.0049 |
| 98 |
SEPTIC EMBOLUS |
4 |
0.0048 |
| 99 |
BACILLUS INFECTION |
3 |
0.0047 |
| 100 |
ACTIVITIES OF DAILY LIVING DECREASED |
3 |
0.0047 |
| 101 |
STREPTOCOCCAL BACTERAEMIA |
5 |
0.0046 |
| 102 |
GLOSSOPTOSIS |
1 |
0.0045 |
| 103 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
7 |
0.0045 |
| 104 |
INFUSION SITE PHLEBITIS |
1 |
0.0044 |
| 105 |
PARENTERAL NUTRITION |
1 |
0.0043 |
| 106 |
METABOLIC ENCEPHALOPATHY |
13 |
0.0043 |
| 107 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
4 |
0.0043 |
| 108 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
2 |
0.0043 |
| 109 |
PELVIC FLUID COLLECTION |
3 |
0.0043 |
| 110 |
EXTRAVASATION BLOOD |
1 |
0.0042 |
| 111 |
ACUTE PULMONARY OEDEMA |
23 |
0.0041 |
| 112 |
PLATELET TRANSFUSION |
5 |
0.0039 |
| 113 |
SCROTAL ULCER |
1 |
0.0038 |
| 114 |
ESCHERICHIA BACTERAEMIA |
9 |
0.0038 |
| 115 |
ENTEROCOLITIS |
22 |
0.0038 |
| 116 |
RESPIRATORY MONILIASIS |
1 |
0.0037 |
| 117 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
3 |
0.0037 |
| 118 |
STAPHYLOCOCCAL BACTERAEMIA |
16 |
0.0037 |
| 119 |
ENTEROCOLITIS BACTERIAL |
1 |
0.0036 |
| 120 |
GENITOURINARY TRACT INFECTION |
1 |
0.0035 |
| 121 |
LEUKAEMIA RECURRENT |
6 |
0.0035 |
| 122 |
PSEUDOMONAL BACTERAEMIA |
3 |
0.0035 |
| 123 |
NEUTROPENIC SEPSIS |
25 |
0.0035 |
| 124 |
CARDIO-RESPIRATORY DISTRESS |
1 |
0.0035 |
| 125 |
ENGRAFT FAILURE |
1 |
0.0035 |
| 126 |
PROCALCITONIN INCREASED |
4 |
0.0034 |
| 127 |
TISSUE INFILTRATION |
1 |
0.0034 |
| 128 |
IDIOPATHIC PNEUMONIA SYNDROME |
1 |
0.0034 |
| 129 |
PNEUMONIA PSEUDOMONAL |
5 |
0.0033 |
| 130 |
ASPERGILLUS TEST POSITIVE |
1 |
0.0032 |
| 131 |
DEVICE RELATED BACTERAEMIA |
1 |
0.0032 |
| 132 |
TUMOUR LYSIS SYNDROME |
28 |
0.0032 |
| 133 |
DEFECT CONDUCTION INTRAVENTRICULAR |
1 |
0.0031 |
| 134 |
CELLULITE |
1 |
0.0031 |
| 135 |
FASCIITIS |
2 |
0.0030 |
| 136 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
217 |
0.0030 |
| 137 |
DEVICE RELATED THROMBOSIS |
3 |
0.0030 |
| 138 |
VASCULAR DEVICE OCCLUSION |
1 |
0.0029 |
| 139 |
THYMOMA |
1 |
0.0028 |
| 140 |
GASTRIC MUCOSAL LESION |
2 |
0.0027 |
| 141 |
PNEUMONIA KLEBSIELLA |
5 |
0.0027 |
| 142 |
ESSENTIAL THROMBOCYTHAEMIA |
1 |
0.0027 |
| 143 |
ENTEROBACTER SEPSIS |
1 |
0.0027 |
| 144 |
LUMBAR PUNCTURE |
1 |
0.0026 |
| 145 |
QRS AXIS ABNORMAL |
2 |
0.0026 |
| 146 |
BONE MARROW FAILURE |
52 |
0.0026 |
| 147 |
STREPTOCOCCAL SEPSIS |
3 |
0.0025 |
| 148 |
ENTEROCOCCAL SEPSIS |
2 |
0.0025 |
| 149 |
CEREBRAL ARTERY EMBOLISM |
3 |
0.0025 |
| 150 |
PSEUDOMONAS TEST POSITIVE |
2 |
0.0024 |
| 151 |
GASTROINTESTINAL ANGIODYSPLASIA |
1 |
0.0024 |
| 152 |
CARDIAC DYSFUNCTION |
9 |
0.0024 |
| 153 |
CARDITIS |
1 |
0.0024 |
| 154 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
2 |
0.0024 |
| 155 |
CITROBACTER INFECTION |
1 |
0.0023 |
| 156 |
ANAL SPHINCTER ATONY |
1 |
0.0023 |
| 157 |
TOXIC SKIN ERUPTION |
23 |
0.0023 |
| 158 |
PNEUMATOSIS |
1 |
0.0022 |
| 159 |
EPSTEIN-BARR VIRUS INFECTION |
14 |
0.0022 |
| 160 |
MENINGOENCEPHALITIS HERPETIC |
1 |
0.0022 |
| 161 |
VENOOCCLUSIVE LIVER DISEASE |
11 |
0.0022 |
| 162 |
BRONCHOPULMONARY ASPERGILLOSIS |
17 |
0.0022 |
| 163 |
ACUTE GRAFT VERSUS HOST DISEASE |
10 |
0.0022 |
| 164 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
5 |
0.0021 |
| 165 |
DEVICE RELATED INFECTION |
33 |
0.0021 |
| 166 |
KLEBSIELLA BACTERAEMIA |
2 |
0.0021 |
| 167 |
GRAFT VERSUS HOST DISEASE IN LUNG |
1 |
0.0021 |
| 168 |
ENCEPHALITIS HERPES |
1 |
0.0020 |
| 169 |
MUCOSAL DISORDER |
2 |
0.0020 |
| 170 |
BLOOD CULTURE POSITIVE |
6 |
0.0020 |
| 171 |
PHARYNGEAL ABSCESS |
1 |
0.0020 |
| 172 |
ERYTHEMA NODOSUM |
7 |
0.0020 |
| 173 |
SEPSIS SYNDROME |
1 |
0.0020 |
| 174 |
DRUG ERUPTION |
35 |
0.0020 |
| 175 |
HERPES ZOSTER OTICUS |
1 |
0.0020 |
| 176 |
MYELOSUPPRESSION |
71 |
0.0020 |
| 177 |
STAPHYLOCOCCUS TEST POSITIVE |
4 |
0.0019 |
| 178 |
PULMONARY MUCORMYCOSIS |
1 |
0.0019 |
| 179 |
RESPIRATORY TRACT INFECTION FUNGAL |
1 |
0.0019 |
| 180 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
19 |
0.0019 |
| 181 |
HEART FAILURE WITH REDUCED EJECTION FRACTION |
1 |
0.0019 |
| 182 |
PERIODONTITIS |
4 |
0.0018 |
| 183 |
BACTERIAL SEPSIS |
6 |
0.0018 |
| 184 |
EPIGLOTTITIS |
1 |
0.0018 |
| 185 |
INTERTRIGO |
1 |
0.0018 |
| 186 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
4 |
0.0018 |
| 187 |
CLOSTRIDIUM TEST POSITIVE |
4 |
0.0018 |
| 188 |
MUCOSAL INFLAMMATION |
47 |
0.0018 |
| 189 |
PULMONARY ALVEOLAR HAEMORRHAGE |
10 |
0.0018 |
| 190 |
CYTOGENETIC ABNORMALITY |
2 |
0.0018 |
| 191 |
SEPTIC SHOCK |
77 |
0.0018 |
| 192 |
BLOOD FIBRINOGEN DECREASED |
2 |
0.0018 |
| 193 |
MEDIASTINITIS |
1 |
0.0017 |
| 194 |
ESCHERICHIA SEPSIS |
5 |
0.0017 |
| 195 |
APLASTIC ANAEMIA |
9 |
0.0017 |
| 196 |
EJECTION FRACTION |
1 |
0.0017 |
| 197 |
DOSE CALCULATION ERROR |
1 |
0.0017 |
| 198 |
ENGRAFTMENT SYNDROME |
1 |
0.0017 |
| 199 |
ESCHERICHIA TEST POSITIVE |
2 |
0.0017 |
| 200 |
SACRAL PAIN |
1 |
0.0016 |
| 201 |
MONOCYTE COUNT DECREASED |
2 |
0.0016 |
| 202 |
MONOCYTOSIS |
1 |
0.0016 |
| 203 |
BILIARY TRACT INFECTION |
1 |
0.0016 |
| 204 |
EJECTION FRACTION DECREASED |
25 |
0.0016 |
| 205 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
1 |
0.0016 |
| 206 |
BRAIN ABSCESS |
4 |
0.0016 |
| 207 |
CONJUNCTIVAL HAEMORRHAGE |
6 |
0.0016 |
| 208 |
VASCULAR DEVICE INFECTION |
7 |
0.0015 |
| 209 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA |
1 |
0.0015 |
| 210 |
HYPERLACTACIDAEMIA |
4 |
0.0015 |
| 211 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 212 |
SIALOADENITIS |
2 |
0.0015 |
| 213 |
MARROW HYPERPLASIA |
1 |
0.0015 |
| 214 |
AORTITIS |
1 |
0.0015 |
| 215 |
ANGULAR CHEILITIS |
1 |
0.0014 |
| 216 |
GRANULOMATOUS LIVER DISEASE |
1 |
0.0014 |
| 217 |
DISSEMINATED INTRAVASCULAR COAGULATION |
20 |
0.0014 |
| 218 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
25 |
0.0014 |
| 219 |
ORGANISING PNEUMONIA |
7 |
0.0014 |
| 220 |
SCROTAL OEDEMA |
1 |
0.0014 |
| 221 |
NEUTROPHIL COUNT DECREASED |
57 |
0.0014 |
| 222 |
PULMONARY SEPSIS |
2 |
0.0014 |
| 223 |
SPONTANEOUS HAEMATOMA |
1 |
0.0013 |
| 224 |
INFECTIOUS PLEURAL EFFUSION |
2 |
0.0013 |
| 225 |
RASH MACULO-PAPULAR |
29 |
0.0013 |
| 226 |
SEPSIS |
142 |
0.0013 |
| 227 |
FUNGAEMIA |
2 |
0.0013 |
| 228 |
PNEUMONIA VIRAL |
4 |
0.0013 |
| 229 |
SINUSITIS FUNGAL |
1 |
0.0012 |
| 230 |
PURPURA |
11 |
0.0012 |
| 231 |
LIVER ABSCESS |
4 |
0.0012 |
| 232 |
POLYCYTHAEMIA VERA |
1 |
0.0012 |
| 233 |
ASPERGILLUS INFECTION |
8 |
0.0012 |
| 234 |
BALANOPOSTHITIS |
1 |
0.0012 |
| 235 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 236 |
DYSCHROMATOPSIA |
1 |
0.0012 |
| 237 |
VENOOCCLUSIVE DISEASE |
3 |
0.0012 |
| 238 |
PERITONSILLAR ABSCESS |
1 |
0.0012 |
| 239 |
SYSTEMIC CANDIDA |
3 |
0.0012 |
| 240 |
ENTEROBACTER INFECTION |
2 |
0.0012 |
| 241 |
SUPERFICIAL VEIN THROMBOSIS |
1 |
0.0012 |
| 242 |
CRANIOFACIAL FRACTURE |
1 |
0.0012 |
| 243 |
HEPATIC HAEMORRHAGE |
1 |
0.0012 |
| 244 |
PSEUDOMONAL SEPSIS |
2 |
0.0011 |
| 245 |
THROMBOPHLEBITIS |
4 |
0.0011 |
| 246 |
ABDOMINAL SEPSIS |
1 |
0.0011 |
| 247 |
PERICARDITIS |
19 |
0.0011 |
| 248 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 249 |
LIQUID PRODUCT PHYSICAL ISSUE |
8 |
0.0011 |
| 250 |
CARDIOMYOPATHY |
16 |
0.0011 |
| 251 |
LUNG CONSOLIDATION |
3 |
0.0011 |
| 252 |
MICROANGIOPATHY |
1 |
0.0011 |
| 253 |
CATHETER SITE INFECTION |
4 |
0.0011 |
| 254 |
ONCOLOGIC COMPLICATION |
1 |
0.0010 |
| 255 |
PULMONARY HAEMORRHAGE |
8 |
0.0010 |
| 256 |
MASTOIDITIS |
1 |
0.0010 |
| 257 |
STAPHYLOCOCCAL SEPSIS |
5 |
0.0010 |
| 258 |
HYPOFIBRINOGENAEMIA |
1 |
0.0010 |
| 259 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 260 |
CYSTITIS HAEMORRHAGIC |
4 |
0.0010 |
| 261 |
CRANIOCEREBRAL INJURY |
3 |
0.0010 |
| 262 |
HEPATOCELLULAR INJURY |
14 |
0.0010 |
| 263 |
ARTHRITIS BACTERIAL |
4 |
0.0010 |
| 264 |
HAEMORRHOIDS |
19 |
0.0010 |
| 265 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
3 |
0.0010 |
| 266 |
SKIN INDURATION |
2 |
0.0010 |
| 267 |
LYMPHANGIOSIS CARCINOMATOSA |
1 |
0.0010 |
| 268 |
ORAL DISORDER |
7 |
0.0010 |
| 269 |
CELLULITIS |
48 |
0.0010 |
| 270 |
NON-CARDIOGENIC PULMONARY OEDEMA |
1 |
0.0009 |
| 271 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
2 |
0.0009 |
| 272 |
CATHETER SITE ERYTHEMA |
2 |
0.0009 |
| 273 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
7 |
0.0009 |
| 274 |
IDIOPATHIC URTICARIA |
1 |
0.0009 |
| 275 |
ANAL ABSCESS |
5 |
0.0009 |
| 276 |
BLADDER DILATATION |
1 |
0.0009 |
| 277 |
GRAFT VERSUS HOST DISEASE IN SKIN |
2 |
0.0009 |
| 278 |
EPSTEIN-BARR VIRAEMIA |
1 |
0.0009 |
| 279 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
1 |
0.0009 |
| 280 |
CEREBRAL HAEMORRHAGE |
32 |
0.0009 |
| 281 |
HYPERSENSITIVITY PNEUMONITIS |
1 |
0.0009 |
| 282 |
IMMUNE THROMBOCYTOPENIA |
4 |
0.0009 |
| 283 |
DIFFUSE ALVEOLAR DAMAGE |
1 |
0.0009 |
| 284 |
PALMAR ERYTHEMA |
1 |
0.0009 |
| 285 |
PERIPHERAL EMBOLISM |
1 |
0.0009 |
| 286 |
SPLENECTOMY |
1 |
0.0009 |
| 287 |
SHOCK HAEMORRHAGIC |
7 |
0.0009 |
| 288 |
SYSTEMIC MYCOSIS |
1 |
0.0009 |
| 289 |
VOLVULUS |
2 |
0.0008 |
| 290 |
LABILE BLOOD PRESSURE |
1 |
0.0008 |
| 291 |
PHYSICAL PRODUCT LABEL ISSUE |
1 |
0.0008 |
| 292 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
0.0008 |
| 293 |
CARDIOGENIC SHOCK |
12 |
0.0008 |
| 294 |
GRAFT VERSUS HOST DISEASE |
6 |
0.0008 |
| 295 |
CHRONIC GRAFT VERSUS HOST DISEASE |
3 |
0.0008 |
| 296 |
CARDIAC DEATH |
1 |
0.0008 |
| 297 |
CLOSTRIDIUM COLITIS |
1 |
0.0008 |
| 298 |
PHARYNGEAL INFLAMMATION |
1 |
0.0008 |
| 299 |
HAEMATOLOGICAL INFECTION |
2 |
0.0008 |
| 300 |
PHARYNGEAL HAEMORRHAGE |
1 |
0.0008 |
| 301 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
23 |
0.0008 |
| 302 |
ACUTE PSYCHOSIS |
2 |
0.0008 |
| 303 |
INTRA-ABDOMINAL HAEMATOMA |
1 |
0.0008 |
| 304 |
CATHETER SITE HAEMORRHAGE |
2 |
0.0008 |
| 305 |
ERYSIPELAS |
4 |
0.0008 |
| 306 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0008 |
| 307 |
TOXIC ENCEPHALOPATHY |
4 |
0.0008 |
| 308 |
HEPATIC CYTOLYSIS |
10 |
0.0008 |
| 309 |
NOCARDIOSIS |
2 |
0.0008 |
| 310 |
INCREASED BRONCHIAL SECRETION |
2 |
0.0008 |
| 311 |
FUNGAL INFECTION |
26 |
0.0008 |
| 312 |
APHTHOUS ULCER |
6 |
0.0008 |
| 313 |
TRANSITIONAL CELL CARCINOMA |
1 |
0.0008 |
| 314 |
CATHETER SITE PAIN |
2 |
0.0008 |
| 315 |
MUCORMYCOSIS |
2 |
0.0008 |
| 316 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
1 |
0.0008 |
| 317 |
LUNG OPACITY |
2 |
0.0008 |
| 318 |
CLOSTRIDIUM DIFFICILE COLITIS |
8 |
0.0008 |
| 319 |
CARDIAC FAILURE ACUTE |
5 |
0.0007 |
| 320 |
BACTERIAL INFECTION |
14 |
0.0007 |
| 321 |
HAEMORRHAGE INTRACRANIAL |
11 |
0.0007 |
| 322 |
BLOOD PHOSPHORUS INCREASED |
2 |
0.0007 |
| 323 |
SUBDURAL HAEMORRHAGE |
2 |
0.0007 |
| 324 |
FAECALOMA |
4 |
0.0007 |
| 325 |
GENERALISED OEDEMA |
9 |
0.0007 |
| 326 |
RHONCHI |
1 |
0.0007 |
| 327 |
DIABETIC METABOLIC DECOMPENSATION |
1 |
0.0007 |
| 328 |
LARGE INTESTINE PERFORATION |
5 |
0.0007 |
| 329 |
THROMBOTIC MICROANGIOPATHY |
7 |
0.0007 |
| 330 |
HYPERPYREXIA |
3 |
0.0007 |
| 331 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
1 |
0.0007 |
| 332 |
ALVEOLITIS |
1 |
0.0007 |
| 333 |
NEUTROPHIL COUNT ABNORMAL |
2 |
0.0007 |
| 334 |
ATYPICAL MYCOBACTERIAL INFECTION |
1 |
0.0007 |
| 335 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 336 |
MYELODYSPLASTIC SYNDROME |
10 |
0.0007 |
| 337 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 338 |
NODAL RHYTHM |
1 |
0.0007 |
| 339 |
MOUTH HAEMORRHAGE |
5 |
0.0007 |
| 340 |
PANCYTOPENIA |
38 |
0.0007 |
| 341 |
DISEASE PROGRESSION |
80 |
0.0007 |
| 342 |
ACUTE RESPIRATORY FAILURE |
13 |
0.0007 |
| 343 |
INFUSION SITE REACTION |
2 |
0.0007 |
| 344 |
MANTLE CELL LYMPHOMA |
1 |
0.0007 |
| 345 |
PRE-EXISTING CONDITION IMPROVED |
4 |
0.0006 |
| 346 |
HAEMORRHAGIC STROKE |
5 |
0.0006 |
| 347 |
MEGACOLON |
1 |
0.0006 |
| 348 |
POLYMYALGIA RHEUMATICA |
2 |
0.0006 |
| 349 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
6 |
0.0006 |
| 350 |
ENTERITIS |
4 |
0.0006 |
| 351 |
GASTROINTESTINAL TOXICITY |
3 |
0.0006 |
| 352 |
ENTEROCOCCAL INFECTION |
3 |
0.0006 |
| 353 |
MYOCARDITIS |
7 |
0.0006 |
| 354 |
NEOPLASM |
7 |
0.0006 |
| 355 |
HYPERVOLAEMIA |
3 |
0.0006 |
| 356 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
2 |
0.0006 |
| 357 |
RESUSCITATION |
1 |
0.0006 |
| 358 |
HYPERNATRAEMIA |
3 |
0.0006 |
| 359 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 360 |
PYREXIA |
206 |
0.0006 |
| 361 |
TONSILLAR HYPERTROPHY |
1 |
0.0006 |
| 362 |
KLEBSIELLA INFECTION |
3 |
0.0006 |
| 363 |
SUPRAVENTRICULAR EXTRASYSTOLES |
2 |
0.0006 |
| 364 |
CEREBELLAR INFARCTION |
1 |
0.0006 |
| 365 |
ARRHYTHMIA |
28 |
0.0006 |
| 366 |
PLATELET COUNT DECREASED |
63 |
0.0006 |
| 367 |
TOOTH ABSCESS |
6 |
0.0006 |
| 368 |
ENTERITIS INFECTIOUS |
1 |
0.0006 |
| 369 |
ENDOCARDITIS |
3 |
0.0006 |
| 370 |
SKIN NECROSIS |
3 |
0.0006 |
| 371 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
1 |
0.0006 |
| 372 |
COMPRESSION FRACTURE |
3 |
0.0006 |
| 373 |
RECTAL HAEMORRHAGE |
24 |
0.0006 |
| 374 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 375 |
HYDROCEPHALUS |
3 |
0.0006 |
| 376 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 377 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0005 |
| 378 |
NECROSIS |
3 |
0.0005 |
| 379 |
ERYTHEMA MULTIFORME |
5 |
0.0005 |
| 380 |
BLOOD IRON INCREASED |
1 |
0.0005 |
| 381 |
HUMAN HERPESVIRUS 6 INFECTION |
1 |
0.0005 |
| 382 |
LIP DISORDER |
1 |
0.0005 |
| 383 |
PERONEAL NERVE PALSY |
3 |
0.0005 |
| 384 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 385 |
HYPERTHERMIA |
4 |
0.0005 |
| 386 |
HERPES VIRUS INFECTION |
3 |
0.0005 |
| 387 |
CHOLESTASIS |
10 |
0.0005 |
| 388 |
PULMONARY OEDEMA |
23 |
0.0005 |
| 389 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 390 |
HAEMOPTYSIS |
14 |
0.0005 |
| 391 |
COLITIS |
19 |
0.0005 |
| 392 |
NEUTROPENIA |
68 |
0.0005 |
| 393 |
EPISTAXIS |
37 |
0.0005 |
| 394 |
DERMATITIS ACNEIFORM |
3 |
0.0005 |
| 395 |
THROMBOCYTOPENIA |
55 |
0.0005 |
| 396 |
RECURRENT CANCER |
2 |
0.0005 |
| 397 |
PERIPHERAL ISCHAEMIA |
2 |
0.0005 |
| 398 |
DIVERTICULAR PERFORATION |
1 |
0.0005 |
| 399 |
VENOUS THROMBOSIS LIMB |
1 |
0.0005 |
| 400 |
PSYCHOTIC SYMPTOM |
1 |
0.0005 |
| 401 |
PETECHIAE |
5 |
0.0005 |
| 402 |
STOMATITIS |
29 |
0.0005 |
| 403 |
LUNG ABSCESS |
1 |
0.0005 |
| 404 |
HALLUCINATIONS, MIXED |
2 |
0.0005 |
| 405 |
URINARY BLADDER HAEMORRHAGE |
1 |
0.0005 |
| 406 |
PSEUDOMONAS INFECTION |
4 |
0.0005 |
| 407 |
PNEUMONIA |
151 |
0.0005 |
| 408 |
PERICARDIAL HAEMORRHAGE |
1 |
0.0005 |
| 409 |
INFECTION |
66 |
0.0005 |
| 410 |
HYPOXIA |
16 |
0.0005 |
| 411 |
CORONAVIRUS INFECTION |
3 |
0.0005 |
| 412 |
ILEUS PARALYTIC |
2 |
0.0004 |
| 413 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 414 |
LARGE INTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 415 |
MYOSITIS |
4 |
0.0004 |
| 416 |
DIVERTICULUM INTESTINAL HAEMORRHAGIC |
1 |
0.0004 |
| 417 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
7 |
0.0004 |
| 418 |
LICHENOID KERATOSIS |
1 |
0.0004 |
| 419 |
NEPHROTIC SYNDROME |
3 |
0.0004 |
| 420 |
PNEUMONIA BACTERIAL |
4 |
0.0004 |
| 421 |
BUNDLE BRANCH BLOCK RIGHT |
2 |
0.0004 |
| 422 |
METASTATIC MALIGNANT MELANOMA |
1 |
0.0004 |
| 423 |
HAEMANGIOMA |
1 |
0.0004 |
| 424 |
HAEMOLYTIC URAEMIC SYNDROME |
1 |
0.0004 |
| 425 |
APHASIA |
13 |
0.0004 |
| 426 |
PERFORMANCE STATUS DECREASED |
2 |
0.0004 |
| 427 |
PLEURAL EFFUSION |
26 |
0.0004 |
| 428 |
RESPIRATORY FAILURE |
31 |
0.0004 |
| 429 |
CHOLECYSTITIS |
5 |
0.0004 |
| 430 |
URINARY RETENTION |
14 |
0.0004 |
| 431 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 432 |
RASH VESICULAR |
2 |
0.0004 |
| 433 |
GUILLAIN-BARRE SYNDROME |
2 |
0.0004 |
| 434 |
LYMPHADENITIS |
1 |
0.0004 |
| 435 |
TRANSPLANT FAILURE |
1 |
0.0004 |
| 436 |
URINARY TRACT INFECTION BACTERIAL |
1 |
0.0004 |
| 437 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 438 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 439 |
ILEOSTOMY |
1 |
0.0004 |
| 440 |
CANCER PAIN |
1 |
0.0004 |
| 441 |
PERICARDIAL EFFUSION |
9 |
0.0004 |
| 442 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 443 |
ATRIOVENTRICULAR BLOCK |
3 |
0.0004 |
| 444 |
CARDIAC FAILURE |
31 |
0.0004 |
| 445 |
HEPATITIS TOXIC |
1 |
0.0004 |
| 446 |
TONSILLITIS |
2 |
0.0004 |
| 447 |
FOLLICULITIS |
4 |
0.0004 |
| 448 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 449 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 450 |
STAPHYLOCOCCAL INFECTION |
12 |
0.0004 |
| 451 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 452 |
CHOLECYSTITIS INFECTIVE |
1 |
0.0004 |
| 453 |
MALNUTRITION |
4 |
0.0004 |
| 454 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 455 |
PROCTITIS |
1 |
0.0004 |
| 456 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 457 |
RENAL TUBULAR DISORDER |
1 |
0.0004 |
| 458 |
SKIN TOXICITY |
2 |
0.0004 |
| 459 |
HAEMATOLOGICAL MALIGNANCY |
1 |
0.0004 |
| 460 |
RASH |
152 |
0.0003 |
| 461 |
GASTROINTESTINAL HAEMORRHAGE |
29 |
0.0003 |
| 462 |
PRODUCT ADMINISTRATION ERROR |
7 |
0.0003 |
| 463 |
STRESS CARDIOMYOPATHY |
2 |
0.0003 |
| 464 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 465 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 466 |
LUNG INFILTRATION |
3 |
0.0003 |
| 467 |
CARDIOTOXICITY |
3 |
0.0003 |
| 468 |
GASTROINTESTINAL INFECTION |
3 |
0.0003 |
| 469 |
THERAPY NON-RESPONDER |
15 |
0.0003 |
| 470 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 471 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 472 |
PROSTATITIS |
1 |
0.0003 |
| 473 |
PHARYNGITIS |
4 |
0.0003 |
| 474 |
HAEMATURIA |
11 |
0.0003 |
| 475 |
MELAENA |
7 |
0.0003 |
| 476 |
HERPES SIMPLEX |
2 |
0.0003 |
| 477 |
ELECTROCARDIOGRAM QT PROLONGED |
11 |
0.0003 |
| 478 |
C-REACTIVE PROTEIN INCREASED |
11 |
0.0003 |
| 479 |
OLIGOHYDRAMNIOS |
1 |
0.0003 |
| 480 |
MENINGITIS |
2 |
0.0003 |
| 481 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 482 |
CANDIDA INFECTION |
5 |
0.0003 |
| 483 |
TONGUE ULCERATION |
1 |
0.0003 |
| 484 |
OEDEMA |
16 |
0.0003 |
| 485 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 486 |
HYPOPNOEA |
1 |
0.0003 |
| 487 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 488 |
AORTIC STENOSIS |
1 |
0.0003 |
| 489 |
EAR PRURITUS |
1 |
0.0003 |
| 490 |
PAPULE |
2 |
0.0003 |
| 491 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 492 |
DEATH |
244 |
0.0003 |
| 493 |
PULMONARY TOXICITY |
2 |
0.0003 |
| 494 |
RETINAL HAEMORRHAGE |
2 |
0.0003 |
| 495 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 496 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 497 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 498 |
AMYLASE INCREASED |
1 |
0.0003 |
| 499 |
HEPATIC FUNCTION ABNORMAL |
10 |
0.0003 |
| 500 |
CHEMOTHERAPY |
1 |
0.0003 |
| 501 |
PROTEINURIA |
5 |
0.0003 |
| 502 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 503 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 504 |
OPTIC ISCHAEMIC NEUROPATHY |
1 |
0.0003 |
| 505 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 506 |
GASTROINTESTINAL INFLAMMATION |
2 |
0.0003 |
| 507 |
DIVERTICULITIS |
7 |
0.0003 |
| 508 |
ATRIAL FLUTTER |
2 |
0.0003 |
| 509 |
AZOTAEMIA |
1 |
0.0003 |
| 510 |
OBSTRUCTION |
1 |
0.0003 |
| 511 |
CREATININE RENAL CLEARANCE DECREASED |
1 |
0.0002 |
| 512 |
HYPERAESTHESIA |
2 |
0.0002 |
| 513 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 514 |
ILEUS |
3 |
0.0002 |
| 515 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 516 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 517 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 518 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 519 |
MONOPLEGIA |
1 |
0.0002 |
| 520 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 521 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 522 |
LUNG DISORDER |
11 |
0.0002 |
| 523 |
BLOOD BILIRUBIN INCREASED |
6 |
0.0002 |
| 524 |
UVEITIS |
3 |
0.0002 |
| 525 |
TACHYPNOEA |
3 |
0.0002 |
| 526 |
SHOCK |
5 |
0.0002 |
| 527 |
SKIN REACTION |
3 |
0.0002 |
| 528 |
WHITE BLOOD CELL COUNT DECREASED |
23 |
0.0002 |
| 529 |
LEUKAEMIA |
2 |
0.0002 |
| 530 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 531 |
PULSE ABSENT |
1 |
0.0002 |
| 532 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 533 |
NON-SMALL CELL LUNG CANCER |
1 |
0.0002 |
| 534 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 535 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 536 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 537 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 538 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 539 |
SUBARACHNOID HAEMORRHAGE |
2 |
0.0002 |
| 540 |
PHLEBITIS |
1 |
0.0002 |
| 541 |
FEMORAL NECK FRACTURE |
1 |
0.0002 |
| 542 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 543 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
0.0002 |
| 544 |
PERITONITIS |
4 |
0.0002 |
| 545 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 546 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 547 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 548 |
MALABSORPTION |
1 |
0.0002 |
| 549 |
MOUTH ULCERATION |
4 |
0.0002 |
| 550 |
SUDDEN DEATH |
2 |
0.0002 |
| 551 |
ANAEMIA |
36 |
0.0002 |
| 552 |
BRADYCARDIA |
10 |
0.0002 |
| 553 |
ANAL FISTULA |
1 |
0.0002 |
| 554 |
HALLUCINATION |
14 |
0.0002 |
| 555 |
ATRIAL FIBRILLATION |
18 |
0.0002 |
| 556 |
VENTRICULAR FIBRILLATION |
2 |
0.0002 |
| 557 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 558 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0002 |
| 559 |
SKIN INFECTION |
2 |
0.0002 |
| 560 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 561 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 562 |
COLECTOMY |
1 |
0.0002 |
| 563 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 564 |
ACUTE KIDNEY INJURY |
27 |
0.0002 |
| 565 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 566 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 567 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 568 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 569 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
4 |
0.0002 |
| 570 |
ASCITES |
5 |
0.0002 |
| 571 |
DEEP VEIN THROMBOSIS |
11 |
0.0002 |
| 572 |
PLEURISY |
1 |
0.0002 |
| 573 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 574 |
LOCALISED INFECTION |
4 |
0.0002 |
| 575 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 576 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 577 |
CEREBRAL INFARCTION |
4 |
0.0002 |
| 578 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 579 |
CHOLANGITIS |
1 |
0.0002 |
| 580 |
OLIGURIA |
1 |
0.0002 |
| 581 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 582 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 583 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 584 |
HEPATITIS ACUTE |
1 |
0.0002 |
| 585 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 586 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 587 |
TOOTH INFECTION |
2 |
0.0002 |
| 588 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 589 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 590 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 591 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 592 |
ALANINE AMINOTRANSFERASE INCREASED |
9 |
0.0001 |
| 593 |
GINGIVAL BLEEDING |
2 |
0.0001 |
| 594 |
FORMICATION |
1 |
0.0001 |
| 595 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 596 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 597 |
SUBDURAL HAEMATOMA |
2 |
0.0001 |
| 598 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 599 |
OFF LABEL USE |
121 |
0.0001 |
| 600 |
LIVER DISORDER |
6 |
0.0001 |
| 601 |
HEPATOTOXICITY |
3 |
0.0001 |
| 602 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 603 |
KETOACIDOSIS |
1 |
0.0001 |
| 604 |
CARDIAC ARREST |
11 |
0.0001 |
| 605 |
PEMPHIGOID |
1 |
0.0001 |
| 606 |
TROPONIN INCREASED |
1 |
0.0001 |
| 607 |
LIPASE INCREASED |
1 |
0.0001 |
| 608 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 609 |
DECREASED APPETITE |
30 |
0.0001 |
| 610 |
RASH PRURITIC |
7 |
0.0001 |
| 611 |
RENAL DISORDER |
6 |
0.0001 |
| 612 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 613 |
NERVOUS SYSTEM DISORDER |
4 |
0.0001 |
| 614 |
PNEUMOTHORAX |
2 |
0.0001 |
| 615 |
COMA |
6 |
0.0001 |
| 616 |
GINGIVAL PAIN |
1 |
0.0001 |
| 617 |
OXYGEN SATURATION DECREASED |
7 |
0.0001 |
| 618 |
INTERSTITIAL LUNG DISEASE |
6 |
0.0001 |
| 619 |
ABNORMAL FAECES |
1 |
0.0001 |
| 620 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 621 |
HAEMODIALYSIS |
1 |
0.0001 |
| 622 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 623 |
HAEMATEMESIS |
3 |
0.0001 |
| 624 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 625 |
SINUSITIS |
12 |
0.0001 |
| 626 |
ANURIA |
1 |
0.0001 |
| 627 |
RASH GENERALISED |
3 |
0.0001 |
| 628 |
CARDIAC MURMUR |
1 |
0.0001 |
| 629 |
INTENTIONAL PRODUCT USE ISSUE |
10 |
0.0001 |
| 630 |
GASTRITIS |
3 |
0.0001 |
| 631 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 632 |
ALOPECIA |
22 |
0.0001 |
| 633 |
HAEMARTHROSIS |
1 |
0.0001 |
| 634 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 635 |
PATHOGEN RESISTANCE |
1 |
0.0001 |
| 636 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 637 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 638 |
HAEMATOCHEZIA |
6 |
0.0001 |
| 639 |
UROSEPSIS |
1 |
0.0001 |
| 640 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 641 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 642 |
BLOOD CREATININE INCREASED |
7 |
0.0001 |
| 643 |
HAEMOGLOBIN DECREASED |
11 |
0.0001 |
| 644 |
NEPHROPATHY |
1 |
0.0001 |
| 645 |
APPENDICITIS |
1 |
0.0001 |
| 646 |
ERYTHEMA |
22 |
0.0001 |
| 647 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 648 |
HAEMATOTOXICITY |
1 |
0.0001 |
| 649 |
GASTRIC ULCER |
2 |
0.0001 |
| 650 |
RASH ERYTHEMATOUS |
5 |
0.0001 |
| 651 |
AFFECT LABILITY |
1 |
0.0001 |
| 652 |
GENERAL PHYSICAL HEALTH DETERIORATION |
12 |
0.0001 |
| 653 |
CHEST PAIN |
19 |
0.0001 |
| 654 |
CHOKING |
2 |
0.0001 |
| 655 |
ORAL HERPES |
2 |
0.0001 |
| 656 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 657 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 658 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 659 |
HEPATOMEGALY |
1 |
0.0001 |
| 660 |
BRAIN INJURY |
1 |
0.0001 |
| 661 |
HYPOTHERMIA |
1 |
0.0001 |
| 662 |
TASTE DISORDER |
2 |
0.0001 |
| 663 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 664 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 665 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 666 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 667 |
HAEMORRHAGE |
10 |
0.0001 |
| 668 |
DERMATITIS |
2 |
0.0001 |
| 669 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 670 |
HYPERTENSION |
20 |
0.0001 |
| 671 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 672 |
SKIN LACERATION |
1 |
0.0001 |
| 673 |
COVID-19 |
16 |
0.0001 |
| 674 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
| 675 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 676 |
TACHYCARDIA |
8 |
0.0001 |
| 677 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 678 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 679 |
RASH PAPULAR |
2 |
0.0001 |
| 680 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 681 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 682 |
FISTULA |
1 |
0.0001 |
| 683 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 684 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 685 |
METASTASES TO LUNG |
1 |
0.0001 |
| 686 |
DELIRIUM |
3 |
0.0001 |
| 687 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 688 |
VASCULITIS |
1 |
0.0001 |
| 689 |
BLADDER CANCER |
5 |
0.0001 |
| 690 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 691 |
ATAXIA |
1 |
0.0001 |
| 692 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 693 |
ACCIDENT |
1 |
0.0001 |
| 694 |
URTICARIA |
14 |
0.0001 |
| 695 |
DRUG INTOLERANCE |
8 |
0.0001 |
| 696 |
PRESYNCOPE |
2 |
0.0001 |
| 697 |
DYSURIA |
3 |
0.0001 |
| 698 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 699 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 700 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 701 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 702 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 703 |
FLUID RETENTION |
4 |
0.0001 |
| 704 |
DRUG RESISTANCE |
2 |
0.0001 |
| 705 |
SKIN ULCER |
2 |
0.0001 |
| 706 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 707 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 708 |
NODULE |
1 |
0.0001 |
| 709 |
PANCREATITIS |
4 |
0.0001 |
| 710 |
CARDIAC FAILURE CONGESTIVE |
6 |
0.0001 |
| 711 |
PNEUMONITIS |
2 |
0.0001 |
| 712 |
SKIN LESION |
2 |
0.0001 |
| 713 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 714 |
RHABDOMYOLYSIS |
3 |
0.0001 |
| 715 |
NO ADVERSE EVENT |
13 |
0.0001 |
| 716 |
CARDIO-RESPIRATORY ARREST |
3 |
0.0001 |
| 717 |
LYMPHOPENIA |
1 |
0.0001 |
| 718 |
DIARRHOEA |
45 |
0.0001 |
| 719 |
SEIZURE |
8 |
0.0001 |
| 720 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 721 |
CONSTIPATION |
15 |
0.0001 |
| 722 |
FLUID OVERLOAD |
1 |
0.0001 |
| 723 |
BONE PAIN |
4 |
0.0001 |
| 724 |
ACUTE MYOCARDIAL INFARCTION |
2 |
0.0001 |
| 725 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 726 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 727 |
PULMONARY MASS |
1 |
0.0001 |
| 728 |
COLON CANCER |
1 |
0.0001 |
| 729 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 730 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 731 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 732 |
HYPOKALAEMIA |
3 |
0.0001 |
| 733 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 734 |
NEUROPATHY PERIPHERAL |
6 |
0.0001 |
| 735 |
ULCER |
1 |
0.0001 |
| 736 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 737 |
MANIA |
1 |
0.0001 |
| 738 |
BACK PAIN |
14 |
0.0001 |
| 739 |
RENAL FAILURE |
8 |
0.0001 |
| 740 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 741 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 742 |
COAGULOPATHY |
1 |
0.0001 |
| 743 |
LEUKOPENIA |
3 |
0.0001 |
| 744 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 745 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 746 |
TRANSIENT ISCHAEMIC ATTACK |
2 |
0.0001 |
| 747 |
HEMIPARESIS |
1 |
0.0001 |
| 748 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 749 |
DRUG INEFFECTIVE |
76 |
0.0001 |
| 750 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 751 |
ECZEMA |
3 |
0.0001 |
| 752 |
PRODUCT STORAGE ERROR |
5 |
0.0001 |
| 753 |
HEART RATE DECREASED |
2 |
0.0001 |
| 754 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 755 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 756 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 757 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 758 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 759 |
TOOTHACHE |
1 |
0.0001 |
| 760 |
OSTEOMYELITIS |
1 |
0.0001 |
| 761 |
ADVERSE EVENT |
5 |
0.0001 |
| 762 |
SWELLING |
5 |
0.0001 |
| 763 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 764 |
NAUSEA |
42 |
0.0001 |
| 765 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 766 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 767 |
HOSPITALISATION |
8 |
0.0001 |
| 768 |
EAR PAIN |
1 |
0.0001 |
| 769 |
SKIN FISSURES |
1 |
0.0001 |
| 770 |
DISABILITY |
1 |
0.0001 |
| 771 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 772 |
HYPOTENSION |
10 |
0.0000 |
| 773 |
THROMBOSIS |
4 |
0.0000 |
| 774 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 775 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
10 |
0.0000 |
| 776 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 777 |
BLINDNESS |
2 |
0.0000 |
| 778 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 779 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 780 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 781 |
ABDOMINAL PAIN |
11 |
0.0000 |
| 782 |
SKIN CANCER |
1 |
0.0000 |
| 783 |
BALANCE DISORDER |
4 |
0.0000 |
| 784 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 785 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 786 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 787 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 788 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 789 |
ORAL PAIN |
1 |
0.0000 |
| 790 |
CHROMATURIA |
1 |
0.0000 |
| 791 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 792 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 793 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 794 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 795 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 796 |
LIVER INJURY |
1 |
0.0000 |
| 797 |
WEIGHT INCREASED |
9 |
0.0000 |
| 798 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 799 |
INFLAMMATION |
2 |
0.0000 |
| 800 |
HAEMATOMA |
1 |
0.0000 |
| 801 |
PALLOR |
1 |
0.0000 |
| 802 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 803 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 804 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 805 |
CONDITION AGGRAVATED |
11 |
0.0000 |
| 806 |
DEMENTIA |
1 |
0.0000 |
| 807 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 808 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 809 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 810 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 811 |
DYSSTASIA |
1 |
0.0000 |
| 812 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 813 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 814 |
HEPATIC FAILURE |
1 |
0.0000 |
| 815 |
EPILEPSY |
1 |
0.0000 |
| 816 |
INJECTION SITE RASH |
1 |
0.0000 |
| 817 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 818 |
CARDIAC DISORDER |
3 |
0.0000 |
| 819 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 820 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 821 |
SWELLING FACE |
2 |
0.0000 |
| 822 |
OSTEONECROSIS |
1 |
0.0000 |
| 823 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 824 |
SKIN DISORDER |
1 |
0.0000 |
| 825 |
VOMITING |
14 |
0.0000 |
| 826 |
MALAISE |
13 |
0.0000 |
| 827 |
RASH MACULAR |
1 |
0.0000 |
| 828 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 829 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 830 |
RESTLESSNESS |
1 |
0.0000 |
| 831 |
DYSGEUSIA |
2 |
0.0000 |
| 832 |
INFLUENZA |
3 |
0.0000 |
| 833 |
EYE SWELLING |
1 |
0.0000 |
| 834 |
DYSARTHRIA |
1 |
0.0000 |
| 835 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 836 |
ARTHRITIS |
2 |
0.0000 |
| 837 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 838 |
COUGH |
7 |
0.0000 |
| 839 |
TREATMENT FAILURE |
2 |
0.0000 |
| 840 |
FALL |
8 |
0.0000 |
| 841 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 842 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 843 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 844 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 845 |
TINNITUS |
1 |
0.0000 |
| 846 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 847 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 848 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 849 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 850 |
HYPOAESTHESIA |
3 |
0.0000 |
| 851 |
SYNCOPE |
2 |
0.0000 |
| 852 |
ASTHENIA |
7 |
0.0000 |
| 853 |
MEDICATION ERROR |
1 |
0.0000 |
| 854 |
HYPONATRAEMIA |
1 |
0.0000 |
| 855 |
EYE PAIN |
1 |
0.0000 |
| 856 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 857 |
HERPES ZOSTER |
1 |
0.0000 |
| 858 |
DYSPHONIA |
1 |
0.0000 |
| 859 |
IRRITABILITY |
1 |
0.0000 |
| 860 |
FEELING HOT |
1 |
0.0000 |
| 861 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 862 |
PRURITUS |
6 |
0.0000 |
| 863 |
RHINORRHOEA |
1 |
0.0000 |
| 864 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 865 |
HEADACHE |
9 |
0.0000 |
| 866 |
INJURY |
1 |
0.0000 |
| 867 |
DYSPNOEA |
8 |
0.0000 |
| 868 |
UNDERDOSE |
1 |
0.0000 |
| 869 |
AGITATION |
1 |
0.0000 |
| 870 |
DIABETES MELLITUS |
1 |
0.0000 |
| 871 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 872 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 873 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 874 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 875 |
BREAST CANCER |
1 |
0.0000 |
| 876 |
FLUSHING |
1 |
0.0000 |
| 877 |
PAIN |
6 |
0.0000 |
| 878 |
FATIGUE |
7 |
0.0000 |
| 879 |
CHILLS |
1 |
0.0000 |
| 880 |
JOINT SWELLING |
1 |
0.0000 |
| 881 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 882 |
PSORIASIS |
1 |
0.0000 |
| 883 |
DEHYDRATION |
1 |
0.0000 |
| 884 |
DRY SKIN |
1 |
0.0000 |
| 885 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 886 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 887 |
DRUG INTERACTION |
1 |
0.0000 |
| 888 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 889 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 890 |
MYALGIA |
1 |
0.0000 |
| 891 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 892 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 893 |
SOMNOLENCE |
1 |
0.0000 |
| 894 |
ARTHRALGIA |
2 |
0.0000 |
| 895 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 896 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 897 |
WEIGHT DECREASED |
1 |
0.0000 |
| 898 |
ANXIETY |
1 |
0.0000 |